Testing effectiveness (Phase 2)Study completedNCT00608972
What this trial is testing
Phase II Trial of Doxil, Carboplatin, Bevacizumab in Triple Negative Untreated Metastatic Breast Cancer
Who this might be right for
Metastatic Breast Cancer
Rutgers, The State University of New Jersey 31